H.C. Wainwright Reiterates Buy Rating on Medicenna Therapeutics (MDNA) Aug 4, 2025 06:38AM
Medicenna Therapeutics (MDNA) Reports MDNA11’s Compelling Anti-Cancer Activity is Associated with Significant Expansion of ‘Stem-Like’ Cancer Fighting Immune Cells Feb 25, 2025 07:05AM
H.C. Wainwright Reiterates Buy Rating on Medicenna Therapeutics (MDNA) Dec 6, 2024 06:49AM
Medicenna Therapeutics (MDNA): Updated MDNA11 Monotherapy and Combination Clinical Data from the Ongoing Phase 1/2 ABILITY-1 Study to be Presented at the 2024 Immunotherapy Bridge Conference Nov 27, 2024 07:02AM
Medicenna Therapeutics (MDNA) Strengthens Board of Directors with Appointment of Karim Lalji Aug 15, 2024 07:31AM